Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality

Stroke

Volumn 45, Issue 7, 2014, Pages 2121-2123

  Mortensen, Janne Kaergaard ^a   Larsson, Heidi ^a   Johnsen, Søren Paaske ^a   Andersen, Grethe ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

hemorrhage; mortality; stroke

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; VERY ELDERLY;

HEMORRHAGE; MORTALITY; STROKE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DENMARK; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; REGISTRIES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; STROKE; YOUNG ADULT;

EID: 84903767788     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005302     Document Type: Article

References (13)

1. Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis. Neurology. 2012;79: 1862-1865.
2. Mortensen JK, Larsson H, Johnsen SP, Andersen G. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: A nationwide propensity score-matched follow-up study. Stroke. 2013;44: 420-426.
3. Dalton SO, Sørensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs. 2006;20: 143-151. (Pubitemid 43261698)
4. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial. Lancet Neurol. 2011;10: 123-130.
5. Ried LD, Jia H, Feng H, Cameon R, Wang X, Tueth M, et al. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality. Ann Pharmacother. 2011;45: 888-897.
6. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke - background and study protocol. Stroke. 1985;16: 885-890.
7. Johnsen SP, Svendsen ML, Hansen ML, Brandes A, Mehnert F, Husted SE. Preadmission oral anticoagulant treatment and clinical outcome among patients hospitalized with acute stroke and atrial fibrillation: A nationwide study. Stroke. 2014;45: 168-175.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40: 373-383. (Pubitemid 17055592)
9. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007;26: 20-36. (Pubitemid 46099415)
10. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 pt 2): 757-763. (Pubitemid 27446562)
11. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10: 150-161.
12. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: A systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134: 1128-1135.
13. Lippi G, Montagnana M, Favaloro EJ, Franchini M. Mental depression and cardiovascular disease: A multifaceted, bidirectional association. Semin Thromb Hemost. 2009;35: 325-336.